Vol. 5, Issue 11 (2019)
Clinical outcomes of administration of oral zinc in children’s Suffering from acute Diarrhoea
Author(s): Dr. Hemant Kumar, Dr. Sanjeev Kumar Sinha
Abstract: Zinc deficiency is common among children in low-income countries due to a variety of factors such as low food intake, particularly from animal sources; limited zinc bioavailability from local diets; and loss of zinc during recurrent diarrhoeal illnesses. Zinc deficiency is associated with immunodeficiency and increased rates of serious infectious diseases. The deficiency is widely recognized as contributing to the limited growth of children in both low-income and high-income countries. It is estimated that zinc deficiency in association with diarrhoea, pneumonia, and malaria contributes to 4.4% of deaths among children aged 6-59 months in Africa, Latin America, and Asia. The World Health Organization now recommends zinc for the treatment of children with diarrhoea because there is sufficient evidence demonstrating that supplementation reduces the severity and duration of the episode. Hence based on above findings the present study was planned for clinical outcomes of administration of oral zinc in children’s suffering from acute diarrhoea. The present study was conducted in Upgraded Department of Paediatrics, Patna Medical College and Hospital, Patna, Bihar, India. In the designed study 100 cases of the acute diarrhoea were evaluated. The 50 cases of the childrens administered with the oral Zinc were enrolled in the study group cases. For comparative evaluation 50 number of control cases were enrolled in control group. Zinc acetate was used as salt in the dose of 20mg once a day orally either in the form of either suspension (20 mg/5ml) or dispersible tablet for 14 days to children of study group. The data generated from present study concludes that administration of oral zinc as an adjuvant therapy in the children hospitalized with diarrhoea was found to significantly reduce the stool frequency.